Top of this page
Skip navigation, go straight to the content

Keppra® (Levetiracetam)

Keppra ® (Levetiracetam) is available as tablets, oral solution and as concentrate for solution for intravenous infusion.   

Keppra is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalization in patients from 16 years of age with newly diagnosed epilepsy.

 

Keppra is indicated as adjunctive therapy:

  • In the treatment of partial onset seizures with or without secondary generalization in adults and children from 1 month of age with epilepsy.
  • In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy. 
  • In the treatment of primary generalized tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalized Epilepsy

 

Keppra solution for infusion is used as an adjunctive therapy in the treatment of partial onset of seizures in adults with epilepsy when oral administration is temporarily not feasible.